Sangamo Biosciences reported $340.06M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Avrobio Inc AVRO:US 170.92M 28.22M
Bayer BAYN:GR 32.58B 633M
IONIS PHARMACEUT IONS:US $ 2345M 189.26M
Novartis NOVN:VX 45.72B 19.46B
Omeros OMER:US $ 210.22M 37.67M
Regulus Therapeutics RGLS:US $ 57.93M 7.3M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Ziopharm Oncology ZIOP:US $ 69.77M 9.06M